🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the efficacy of phospha...
Status
Terminated
Location
Cleveland Clinic Foundation
Start Date
2009-02
Trial ID
NCT00851747
Treatments Being Tested
A blood clot in the veins, also known as deep venous thrombosis (DVT), is o...
Status
Completed
Location
Barnes-Jewish Hospital
Start Date
2006-05
Trial ID
NCT00329433
Treatments Being Tested
This study is a phase I, single-center, randomized, double-blind, placebo-c...
Status
Not Yet Recruiting
Location
Veritus Research
Start Date
2026-02
Trial ID
NCT07432698
To assess the clinical efficacy and safety of certolizumab pegol as add-on ...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00674362
Treatments Being Tested
Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04008290
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled single ascendi...
Status
Unknown
Location
Huashan hospital
Start Date
2024-08-06
Trial ID
NCT06501573
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This is a phase 1/2a double-blinded, placebo-controlled, dose-escalating st...
Status
Recruiting
Location
Liverpool Hospital
Start Date
2024-03-04
Trial ID
NCT06138743
Treatments Being Tested
IMO 8400 is a second-generation oligonucleotide antagonist of endosomal Tol...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2013-05
Trial ID
NCT01899729
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled Phase Ⅱ clinical stu...
Status
Completed
Location
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Start Date
2023-12-20
Trial ID
NCT06194188
Treatments Being Tested